Pipeline

Pipeline

Savara has multiple products in various stages of clinical development.

  • Savara expects to start enrollment of patients in a pivotal phase III clinical trial of AeroVanc in cystic fibrosis patients with chronic MRSA infection in the U.S. and Canada in Q1 of 2017. See AeroVanc.com for more details.
  • A phase II/III clinical trial of Molgradex to treat patients with PAP is on-going in the EU and Japan.

Go to products

Back to Top